array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Mon, 25 Nov 2024 01:27:29 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6Inp3SWJVUlE4RS96V2F3RUNESDMrNnc9PSIsInZhbHVlIjoiRnlXUWU1L2QxSGRWZ1IwbXRTajVmVU04V2Q4SXo4WWZrZkNlSGhVUW15bkN3VE8zRUlOTXVqNnpGMHRBSllYL3pncU1Ld2pYeGpnQkVvV0xVaDJtZ2VBQ3dTYlQvMGJBbHcwSkVhT3ZwSnl0a0dFS0xOWnBLTTFUL253c1NhVlkiLCJtYWMiOiIwNzQ2ZjQyODU2MDAyNDM0NDM3ZDRmOTMyZWQzYTM0YWY5NTJmMGMyOTMyYmJjZDkxMTZiZTljNzM0NWQ5NWE4IiwidGFnIjoiIn0%3D; expires=Tue, 25 Nov 2025 01:27:29 GMT; Max-Age=31536000; path=/; secure; samesite=lax"
    1 => "republica_session=eyJpdiI6ImU0RXdoOExZNjU2SzhZSnJIcnNLbnc9PSIsInZhbHVlIjoiZmUyV1Q1TFNyU0JKVDY0RW1KMkRSSmpDN1BMcDdIQlZtL2tNUnlxTWUrUlhTOWxrQWFmMGFqQktXL3h6MDRQZHlxVWlFQjNyQ1dmY2JadlZ1SVB2YTNmRVEyVmEzOFBkSVU5anhwZWZuT1JZdlVQK29Hbk5EN3ZrZE4vTXhsVlYiLCJtYWMiOiIzODIwMWEwN2ZiNzJkYWVmMjEwZjFjM2EwZTFjZDM4MGFjZDQyYmRiMTExNmI1MjQ3ODUzOTRmOGUwZDJhOWI0IiwidGFnIjoiIn0%3D; expires=Tue, 25 Nov 2025 01:27:29 GMT; Max-Age=31536000; path=/; secure; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6Inp3SWJVUlE4RS96V2F3RUNESDMrNnc9PSIsInZhbHVlIjoiRnlXUWU1L2QxSGRWZ1IwbXRTajVmVU04V2Q4SXo4WWZrZkNlSGhVUW15bkN3VE8zRUlOTXVqNnpGMHRBSllYL3pncU1Ld2pYeGpnQkVvV0xVaDJtZ2VBQ3dTYlQvMGJBbHcwSkVhT3ZwSnl0a0dFS0xOWnBLTTFUL253c1NhVlkiLCJtYWMiOiIwNzQ2ZjQyODU2MDAyNDM0NDM3ZDRmOTMyZWQzYTM0YWY5NTJmMGMyOTMyYmJjZDkxMTZiZTljNzM0NWQ5NWE4IiwidGFnIjoiIn0%3D; expires=Tue, 25-Nov-2025 01:27:29 GMT; path=/; secure"
    1 => "republica_session=eyJpdiI6ImU0RXdoOExZNjU2SzhZSnJIcnNLbnc9PSIsInZhbHVlIjoiZmUyV1Q1TFNyU0JKVDY0RW1KMkRSSmpDN1BMcDdIQlZtL2tNUnlxTWUrUlhTOWxrQWFmMGFqQktXL3h6MDRQZHlxVWlFQjNyQ1dmY2JadlZ1SVB2YTNmRVEyVmEzOFBkSVU5anhwZWZuT1JZdlVQK29Hbk5EN3ZrZE4vTXhsVlYiLCJtYWMiOiIzODIwMWEwN2ZiNzJkYWVmMjEwZjFjM2EwZTFjZDM4MGFjZDQyYmRiMTExNmI1MjQ3ODUzOTRmOGUwZDJhOWI0IiwidGFnIjoiIn0%3D; expires=Tue, 25-Nov-2025 01:27:29 GMT; path=/; secure; httponly"
  ]
]
India backs AstraZeneca shot as COVID-19 cases hit three-month high

India backs AstraZeneca shot as COVID-19 cases hit three-month high

Create an account, or log in
